Affinium Pharma Raises Series A

Affinium Pharmaceuticals Inc., a Toronto-based developer of oral antibacterial therapeutics, has raised US$18 million in Series A funding. Forward Ventures led the deal, and was joined by Oxford Bioscience Partners, SV Life Sciences and seed backer Genesys Capital Partners. www.afnm.com